The guidelines are designed primarily for healthcare providers who manage patients with influenza virus infection and will also serve as a reference source for policymakers and...
The mRNA Technology Transfer Programme, jointly developed by WHO and MPP, was launched in July 2021 with the aim to build capacity in low- and middle-income countries (LMICs) ...